Digital health company Livongo Health has raised $105 million, which it will use to try to expand its market share and integrate with partners, among other initiatives.
Livongo, which offers a chronic disease management platform, raised the cash at a time when there is a lot of interest in investing in digital health.
The company currently focuses on diabetes and hypertension with its patient-focused connected meters and app-based coaching. Livongo will also use the proceeds from this most recent funding round—led by General Catalyst and Kinnevik—to broaden the use its platform.
"We are committed to expanding our chronic conditions management platform," said Dr. Jennifer Schneider, Livongo's chief medical officer. "We know that to care for the whole person, we must offer solutions to better manage multiple chronic conditions, since most of us living with one chronic condition have a second or third as well."
The company has offered the diabetes platform since 2014 and introduced the hypertension program this January. Employers, health plans and health systems offer the platforms to employees, members and patients.
Along with the funding, Livongo also announced a partnership with insurer Cambia Health Solutions to bring Livongo's diabetes platform to Cambia members. The two companies will work together on new capabilities to support Livongo's so-called "whole person" philosophy of personalized experiences for each patient.
A year ago, after raising $52.5 million, CEO Glen Tullman said he expected the company to eventually introduce the platform for high cholesterol, weight management, pre-diabetes, and depression.
